GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Almeda Ventures LP (XTAE:AMDA) » Definitions » Current Deferred Revenue

Almeda Ventures LP (XTAE:AMDA) Current Deferred Revenue : ₪0.00 Mil (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Almeda Ventures LP Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Almeda Ventures LP's current deferred revenue for the quarter that ended in . 20 was ₪0.00 Mil.

Almeda Ventures LP Current Deferred Revenue Historical Data

The historical data trend for Almeda Ventures LP's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Almeda Ventures LP Current Deferred Revenue Chart

Almeda Ventures LP Annual Data
Trend
Current Deferred Revenue

Almeda Ventures LP Semi-Annual Data
Current Deferred Revenue

Almeda Ventures LP Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Almeda Ventures LP's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Almeda Ventures LP Business Description

Traded in Other Exchanges
N/A
Address
141 Menachem Begin Street, Azrieli Center, Triangle Tower, 45th Floor, Tel Aviv, ISR, 67023
Almeda Ventures LP is a life science research and development company. The company invests in Medical devices and Digital health businesses. Its portfolio includes BioProtect which developed a proprietary technology platform for biodegradable balloons. The technology suits a range of clinical applications including spacing for radiation oncology protection, and general surgery. TailorMed technology improves the financial performance of healthcare providers and reduces financial hardship for patients.

Almeda Ventures LP Headlines

No Headlines